Pathogenesis and current status of the treatment of lung cancer associated with idiopathic pulmonary fibrosis
Abstract Idiopathic pulmonary fibrosis (IPF) is an interstitial lung disease with chronic progressive fibrosis of unknown etiology; it is characterized by persistent fibrosis of the lungs accompanied by irreversible lung function decline and high mortality rates. A large body of evidence suggests a...
Saved in:
| Main Authors: | Yuanyuan Zhang, Chang Qi, Qi Wei, Yalun Li, Panwen Tian |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-07-01
|
| Series: | Respiratory Research |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12931-025-03294-7 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Idiopathic Pulmonary Fibrosis, Today and Tomorrow: Certainties and New Therapeutic Horizons
by: Giacomo Giulianelli, et al.
Published: (2025-05-01) -
Extracellular Vesicles in Idiopathic Pulmonary Fibrosis: Pathogenesis, Biomarkers and Innovative Therapeutic Strategies
by: Yang Y, et al.
Published: (2024-11-01) -
The immune mechanisms of acute exacerbations of idiopathic pulmonary fibrosis
by: Tao Chen, et al.
Published: (2024-12-01) -
Nomogram model using serum Club cell secretory protein 16 to predict prognosis and acute exacerbation in patients with idiopathic pulmonary fibrosis
by: Yaqiong Tian, et al.
Published: (2025-01-01) -
Composition and modification of the lung microbiome in patients with idiopathic pulmonary fibrosis
by: Victoria Maria Ruta, et al.
Published: (2020-10-01)